These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12710653)

  • 1. Rehospitalization for respiratory syncytial virus infection in infants with extremely low gestational age or birthweight in Denmark.
    Pedersen O; Herskind AM; Kamper J; Nielsen JP; Kristensen K
    Acta Paediatr; 2003; 92(2):240-2. PubMed ID: 12710653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.
    McLaurin KK; Farr AM; Wade SW; Diakun DR; Stewart DL
    J Perinatol; 2016 Nov; 36(11):990-996. PubMed ID: 27490190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Age With Risk of Hospitalization for Respiratory Syncytial Virus in Preterm Infants With Chronic Lung Disease.
    Winterstein AG; Choi Y; Meissner HC
    JAMA Pediatr; 2018 Feb; 172(2):154-160. PubMed ID: 29204660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of respiratory syncytial virus infection requiring hospitalization in East Denmark.
    Kristensen K; Dahm T; Frederiksen PS; Ibsen J; Iyore E; Jensen AM; Kjaer BB; Olofsson K; Pedersen P; Poulsen S
    Pediatr Infect Dis J; 1998 Nov; 17(11):996-1000. PubMed ID: 9849981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany.
    Liese JG; Grill E; Fischer B; Roeckl-Wiedmann I; Carr D; Belohradsky BH;
    Eur J Pediatr; 2003 Apr; 162(4):230-6. PubMed ID: 12647195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002.
    Henckel E; Luthander J; Berggren E; Kapadia H; Naver L; Norman M; Bennet R; Eriksson M
    Pediatr Infect Dis J; 2004 Jan; 23(1):27-31. PubMed ID: 14743042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis for respiratory syncytial virus with respiratory syncytial virus-immunoglobulin intravenous among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost.
    Atkins JT; Karimi P; Morris BH; McDavid G; Shim S
    Pediatr Infect Dis J; 2000 Feb; 19(2):138-43. PubMed ID: 10694001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rehospitalization for respiratory syncytial virus among premature infants.
    Joffe S; Escobar GJ; Black SB; Armstrong MA; Lieu TA
    Pediatrics; 1999 Oct; 104(4 Pt 1):894-9. PubMed ID: 10506231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain.
    Figueras-Aloy J; Carbonell-Estrany X; Quero J;
    Pediatr Infect Dis J; 2004 Sep; 23(9):815-20. PubMed ID: 15361718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.
    Figueras-Aloy J; Carbonell-Estrany X; Quero-Jiménez J; Fernández-Colomer B; Guzmán-Cabañas J; Echaniz-Urcelay I; Doménech-Martínez E;
    Pediatr Infect Dis J; 2008 Sep; 27(9):788-93. PubMed ID: 18664927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.
    Pedraz C; Carbonell-Estrany X; Figueras-Aloy J; Quero J;
    Pediatr Infect Dis J; 2003 Sep; 22(9):823-7. PubMed ID: 14506376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis.
    Heikkinen T; Valkonen H; Lehtonen L; Vainionpää R; Ruuskanen O
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F64-8. PubMed ID: 15613580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Evidence in Israel Supporting Reevaluation of Respiratory Syncytial Virus Prophylactic Guidelines.
    Gross I; Siedner-Weintraub Y; Abu Ahmad W; Bar-Oz B; Eventov-Friedman S
    Neonatology; 2017; 111(3):240-246. PubMed ID: 27898422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis.
    Stevens TP; Sinkin RA; Hall CB; Maniscalco WM; McConnochie KM
    Arch Pediatr Adolesc Med; 2000 Jan; 154(1):55-61. PubMed ID: 10632251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory syncytial virus hospitalizations in infants of 28 weeks gestational age and less in the palivizumab era.
    Resch B; Egger B; Kurath-Koller S; Urlesberger B
    Int J Infect Dis; 2017 Apr; 57():50-53. PubMed ID: 28163166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation.
    Law BJ; Langley JM; Allen U; Paes B; Lee DS; Mitchell I; Sampalis J; Walti H; Robinson J; O'Brien K; Majaesic C; Caouette G; Frenette L; Le Saux N; Simmons B; Moisiuk S; Sankaran K; Ojah C; Singh AJ; Lebel MH; Bacheyie GS; Onyett H; Michaliszyn A; Manzi P; Parison D
    Pediatr Infect Dis J; 2004 Sep; 23(9):806-14. PubMed ID: 15361717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthy Late-preterm infants born 33-36+6 weeks gestational age have higher risk for respiratory syncytial virus hospitalization.
    Helfrich AM; Nylund CM; Eberly MD; Eide MB; Stagliano DR
    Early Hum Dev; 2015 Sep; 91(9):541-6. PubMed ID: 26186560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory Syncytial Virus Associated Hospitalizations in Infants of 33 to 42 Weeks' Gestation: Does Gestational Age Matter?
    Resch B; Wörner C; Özdemir S; Hubner M; Puchas C; Urlesberger B
    Klin Padiatr; 2019 Jul; 231(4):206-211. PubMed ID: 30887492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group.
    Carbonell-Estrany X; Quero J; Bustos G; Cotero A; Doménech E; Figueras-Aloy J; Fraga JM; García LG; García-Alix A; Del Río MG; Krauel X; Sastre JB; Narbona E; Roqués V; Hernández SS; Zapatero M
    Pediatr Infect Dis J; 2000 Jul; 19(7):592-7. PubMed ID: 10917214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.